Cigna Corp. buy UBS Group AG
Start price
03.02.25
/
50%
€285.60
Target price
03.02.26
€379.08
Performance (%)
-18.79%
End price
04.02.26
€231.95
Summary
This prediction ended on 04.02.26 with a price of €231.95. The price of Cigna Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.79%. UBS_Group_AG has a follow-up prediction for Cigna Corp. where he still thinks Cigna Corp. is a Buy. Dividends of €1.40 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cigna Corp. | -2.938% | -2.938% | -5.708% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % |
Comments by UBS_Group_AG for this prediction
In the thread Cigna Corp. diskutieren
The Cigna Group (NYSE: CI) had its price target lowered by analysts at UBS Group AG from $410.00 to $390.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
In the thread Trading Cigna Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

